Dr. Kenny is the Ward-Coleman Professor and Chairman of the Department of Neuroscience and Director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai in New York. He received a degree in biochemistry from Trinity College Dublin and his Ph.D. in psychopharmacology from King’s College London. He completed his post-doctoral training in neuropharmacology at The Scripps Research Institute in La Jolla, California. Research in Dr. Kenny’s laboratory is focused on the molecular neurobiology of drug addiction, obesity and schizophrenia. Dr. Kenny is also involved in efforts to develop novel small molecule therapeutic agents for the treatment of drug addiction and other psychiatric indications, and is the co-founder of Eolas Therapeutics, Inc. Dr. Kenny is a handling editor for the Journal of Neuroscience and a member of the National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA). Dr. Kenny has won numerous awards for his research, including the Jacob P. Waletzky Memorial Award, Society for Neuroscience and the Tom Connor Distinguished Investigator Award, Neuroscience.